Key elements of nutritional priorities to support GLP-1 therapy for obesity (A joint advisory from the American Society for Nutrition, the American College of Lifestyle medicine, the Obesity Medicine Association and the Obesity Society) Did you know WholisticMatters is powered by Standard Process
Placebo groups experienced diarrhea at 10-13%, establishing the baseline noise
Smaller, more frequent meals may be better tolerated than large portions, especially during the initial titration phase when side effects are most common
Gut-brain axis signaling: The gut communicates with the brain through hormones such as GLP-1, peptide YY (PYY), and cholecystokinin (CCK)
Conversely, if you are experiencing severe appetite loss and eating too little, the diary helps identify that problem early
Given these anti-inflammatory effects, there is speculation that GLP-1 medicines could impair host immune defenses